InsidersTradesSigma
Explore the complete record of transactions filed by CORRIGAN MARK, Director. Director active across 1 companies, notably Nabriva Therapeutics plc. In total, 2 filings have been logged. The latest transaction was filed on 28 July 2021 (Attribution). Regulator: SEC (Form 4). All data is free.
2 of 2 declarations
Mark Corrigan is a Board Member at Nabriva Therapeutics plc. He contributes to the governance of the company by participating in strategic decision-making and ensuring operational compliance. His role is important for the success and growth of the company.